Posted in Business Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment Estimated read time 2 min read Posted on June 26, 2025 by Joelgalvan Argenx (NASDAQ:ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the…
